Amphastar Pharmaceuticals Inc (AMPH)
Cost of Revenue
$90.43M
Quarterly · Period ending: · USD
AMPH Cost of Revenue
Latest reported$90.43Mperiod ending
Latest reported$90.43Mperiod ending
AMPH Quarterly Cost of Revenue ($30.28M → $90.43M)
Quarterly cost of revenue
High-resolution chart · PNG
AMPH cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 90,433,000 | |
| 100,849,000 | |
| 97,435,000 | |
| 93,194,000 | |
| 87,924,000 | |
| 85,277,000 | |
| 99,875,000 | |
| 86,878,000 | |
| 87,228,000 | |
| 84,546,000 | |
| 81,965,000 | |
| 72,153,000 | |
| 72,974,000 | |
| 66,182,000 | |
| 63,855,000 | |
| 61,619,000 | |
| 60,111,000 | |
| 64,542,000 | |
| 64,653,000 | |
| 61,015,000 | |
| 54,287,000 | |
| 58,074,000 | |
| 59,089,000 | |
| 46,923,000 | |
| 52,629,000 | |
| 47,865,000 | |
| 50,002,000 | |
| 44,885,000 | |
| 46,660,000 | |
| 48,887,000 | |
| 55,001,000 | |
| 46,283,000 | |
| 44,884,000 | |
| 41,332,000 | |
| 39,823,000 | |
| 37,275,000 | |
| 38,440,000 | |
| 33,842,000 | |
| 43,582,000 | |
| 36,611,000 | |
| 36,319,000 | |
| 34,464,000 | |
| 43,741,000 | |
| 46,290,000 | |
| 40,535,000 | |
| 43,606,000 | |
| 43,916,000 | |
| 47,920,000 | |
| 34,007,000 | |
| 33,362,000 | |
| 35,247,000 | |
| 39,038,000 | |
| 35,035,000 | |
| 33,406,000 | |
| 30,280,000 |